BKG-PHARMA ApS: Financial statements 2014
CVR: 27959350
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
BKG-PHARMA ApS (CVR 27959350) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -28,158 and a net result of DKK -65,498 compared with DKK 791,513 the year before. Equity in the 2014 report amounted to DKK 14,482,567. The solvency ratio was 92.7%.
- Gross Profit
- DKK -28,158
- Profit/Loss
- DKK -65,498
- Equity
- DKK 14,482,567
- Total Assets
- DKK 15,622,501
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -28 t. | -65 t. | 14.5 mio. | - |
| 2013 | - | 938 t. | 792 t. | 14.5 mio. | - |
| 2012 | - | 837 t. | 535 t. | 13.8 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of September 16, 2014, Rasmus Schmiegelow is registered as chairman of BKG-PHARMA ApS.
As of June 24, 2014, Morten Stadil has stepped down as chairman of BKG-PHARMA ApS.
BKG-PHARMA ApS has published its annual report for 2013. Gross profit came to DKK 937,848, and the net result was DKK 791,513.
As of April 11, 2014, Jeppe Viggo Christensen has left the board of directors of BKG-PHARMA ApS.
About BKG-PHARMA ApS
BKG-PHARMA ApS was a Danish company of the type Anpartsselskab based in Klampenborg, founded in 2004. The company has been dissolved on 27 December 2017. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 0 employees (2018). In 2016, the company reported a gross profit of DKK -616,406 and a net result of DKK -18,025,433 compared with DKK -94,523 the year before. Equity in the 2016 report amounted to DKK -2,682,678.